Advances in soft mist inhalers

V Komalla, CYJ Wong, I Sibum… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Soft mist inhalers (SMIs) are propellant-free inhalers that utilize
mechanical power to deliver single or multiple doses of inhalable drug aerosols in the form …

Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases

H Douafer, V Andrieu, JM Brunel - Journal of Controlled Release, 2020 - Elsevier
The rise of antimicrobial resistance has created an urgent need for the development of new
methods for antibiotics delivery to patients with pulmonary infections in order to mainly …

Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease

M Cazzola, F Cavalli, OS Usmani… - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction Proper device selection is crucial for the clinical results of inhalation therapy.
However, none of the available devices fully conforms to the requirements for delivering …

Inhaler technique in asthma and COPD: challenges and unmet knowledge that can contribute to suboptimal use in real life

AS Melani - Expert Review of Clinical Pharmacology, 2021 - Taylor & Francis
Introduction: Inhalers are the most commonly used devices for lung drug delivery in asthma
and COPD. Inhaler use offers several advantages but requires the user's proper mastery …

[HTML][HTML] Tiotropium/olodaterol: a review in COPD

HA Blair - Drugs, 2019 - Springer
Abstract Tiotropium/olodaterol (Stiolto® Respimat®; Spiolto® Respimat®) is an inhaled fixed-
dose combination of the long-acting muscarinic antagonist tiotropium bromide (hereafter …

Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis

P Nickolaus, B Jung, J Sabater, S Constant… - ERJ Open …, 2020 - Eur Respiratory Soc
Background Epithelial sodium channel (ENaC) is an important regulator of airway surface
liquid volume; ENaC is hyperactivated in cystic fibrosis (CF). ENaC inhibition is a potential …

[HTML][HTML] Aerosol delivery via invasive ventilation: a narrative review

HL Lin, JB Fink, H Ge - Annals of Translational Medicine, 2021 - ncbi.nlm.nih.gov
In comparison with spontaneously breathing non-intubated subjects, intubated,
mechanically ventilated patients encounter various challenges, barriers, and opportunities in …

Lung Deposition Using the Respimat® Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An In Vitro/In Silico Analysis

AM Ciciliani, M Denny, P Langguth… - COPD: Journal of …, 2020 - Taylor & Francis
Tiotropium and olodaterol are mainstay treatments for chronic obstructive pulmonary
disease (COPD) and yield important clinical improvements, especially when used in fixed …

[HTML][HTML] A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux

G Ortsäter, F Borgström, S Soulard, C Miltenburger - Advances in Therapy, 2019 - Springer
Introduction The healthcare sector contributes 5–8% of the global greenhouse gas
emissions. Global and regional organizations and governments have started to design and …

Tunable rigidity of PLGA shell-lipid core nanoparticles for enhanced pulmonary siRNA delivery in 2D and 3D lung cancer cell models

H Wang, Y Yuan, L Qin, M Yue, J Xue, Z Cui… - Journal of Controlled …, 2024 - Elsevier
Faced with the threat of lung cancer-related deaths worldwide, small interfering RNA
(siRNA) can silence tumor related messenger RNA (mRNA) to tackle the issue of drug …